A blood-brain barrier-penetrant AAV gene therapy improves neurological function in symptomatic mucolipidosis IV mice

Mucolipidosis IV (MLIV) is a rare, autosomal recessive, lysosomal disease characterized by intellectual disability, motor deficits, and progressive vision loss. Using adeno-associated vector 9 (AAV9) and AAV-PHP.B as delivery vectors, we previously demonstrated the feasibility of modifying disease c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Madison L. Sangster, Martha M. Bishop, Yizheng Yao, Jessica F. Feitor, Sanjid Shahriar, Maxwell E. Miller, Anil K. Chekuri, Bogdan Budnik, Fengfeng Bei, Yulia Grishchuk
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-06-01
coleção:	Molecular Therapy: Methods & Clinical Development
Assuntos:	TRPML1 lysosomal disorder AAV adeno-associated vector gene transfer pediatric neurological disease
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2329050124000858
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!